NVWM LLC’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.64M | Sell |
5,275
-57
| -1% | -$27.4K | 0.53% | 50 |
|
|
2026
Q1 | $2.62M | Buy |
5,332
+4
| +0.1% | +$2.17K | 0.58% | 46 |
|
|
2025
Q4 | $3.09M | Sell |
5,328
-155
| -3% | -$87.7K | 0.67% | 40 |
|
|
2025
Q3 | $2.66M | Buy |
5,483
+98
| +2% | +$45.6K | 0.6% | 44 |
|
|
2025
Q2 | $2.18M | Buy |
5,385
+529
| +11% | +$221K | 0.53% | 51 |
|
|
2025
Q1 | $2.42M | Buy |
4,856
+1,755
| +57% | +$951K | 0.64% | 40 |
|
|
2024
Q4 | $1.61M | Buy |
3,101
+22
| +0.7% | +$12.1K | 0.41% | 66 |
|
|
2024
Q3 | $1.9M | Buy |
3,079
+24
| +0.8% | +$14.2K | 0.48% | 51 |
|
|
2024
Q2 | $1.69M | Buy |
3,055
+75
| +3% | +$43K | 0.45% | 57 |
|
|
2024
Q1 | $1.73M | Sell |
2,980
-24
| -0.8% | -$13.5K | 0.48% | 62 |
|
|
2023
Q4 | $1.6M | Sell |
3,004
-1,485
| -33% | -$719K | 0.48% | 58 |
|
|
2023
Q3 | $2.27M | Buy |
4,489
+55
| +1% | +$29.3K | 0.74% | 39 |
|
|
2023
Q2 | $2.31M | Buy |
4,434
+144
| +3% | +$77.7K | 0.75% | 35 |
|
|
2023
Q1 | $2.47M | Sell |
4,290
-76
| -2% | -$42.8K | 0.83% | 30 |
|
|
2022
Q4 | $2.41M | Sell |
4,366
-14
| -0.3% | -$7.42K | 0.87% | 23 |
|
|
2022
Q3 | $2.22M | Buy |
4,380
+58
| +1% | +$32.5K | 0.88% | 21 |
|
|
2022
Q2 | $2.35M | Sell |
4,322
-641
| -13% | -$353K | 0.91% | 20 |
|
|
2022
Q1 | $2.93M | Buy |
4,963
+123
| +3% | +$70.7K | 0.93% | 13 |
|
|
2021
Q4 | $3.23M | Buy |
4,840
+129
| +3% | +$80.5K | 1.01% | 17 |
|
|
2021
Q3 | $2.69M | Sell |
4,711
-61
| -1% | -$33.5K | 0.97% | 19 |
|
|
2021
Q2 | $2.41M | Buy |
4,772
+2,309
| +94% | +$1.09M | 0.87% | 23 |
|
|
2021
Q1 | $1.12M | Buy |
2,463
+27
| +1% | +$12.9K | 0.45% | 69 |
|
|
2020
Q4 | $1.14M | Sell |
2,436
-565
| -19% | -$265K | 0.47% | 67 |
|
|
2020
Q3 | $1.32M | Sell |
3,001
-26
| -0.9% | -$10.7K | 0.62% | 48 |
|
|
2020
Q2 | $1.1M | Buy |
3,027
+2
| +0.1% | +$670 | 0.59% | 49 |
|
|
2020
Q1 | $858K | Buy |
3,025
+118
| +4% | +$37.2K | 0.6% | 46 |
|
|
2019
Q4 | $944K | Sell |
2,907
-403
| -12% | -$122K | 0.57% | 49 |
|
|
2019
Q3 | $964K | Buy |
3,310
+20
| +0.6% | +$5.73K | 0.59% | 42 |
|
|
2019
Q2 | $966K | Sell |
3,290
-1,247
| -27% | -$343K | 0.58% | 41 |
|
|
2019
Q1 | $1.24M | Buy |
4,537
+145
| +3% | +$36.1K | 0.82% | 37 |
|
|
2018
Q4 | $983K | Buy |
4,392
+26
| +0.6% | +$6.1K | 0.74% | 41 |
|
|
2018
Q3 | $1.07M | Buy |
4,366
+135
| +3% | +$31.1K | 0.67% | 45 |
|
|
2018
Q2 | $877K | Buy |
4,231
+242
| +6% | +$51.4K | 0.61% | 52 |
|
|
2018
Q1 | $811K | Buy |
3,989
+1,127
| +39% | +$237K | 0.59% | 52 |
|
|
2017
Q4 | $544K | Buy |
+2,862
| New | +$548K | 0.42% | 80 |
|
Other funds holding TMO
RG
NVWM LLC's TMO Position: Q2 2026 in Review
NVWM LLC reduced its Thermo Fisher Scientific (TMO) stake by 1.1% in Q2 2026, selling an estimated $27.4K and leaving 5,275 shares worth $2.64M. The position accounts for 0.53% of the portfolio, ranked #50.
NVWM LLC first reported a position in TMO in Q4 2017 and has held it in 35 quarters since. The position peaked at $3.23M in Q4 2021. 1,244 funds tracked by Wall St. Rank hold TMO as of Q2 2026.
- NVWM LLC held 5,275 shares of Thermo Fisher Scientific worth $2.64M as of Q2 2026.
- NVWM LLC sold 57 Thermo Fisher Scientific shares in Q2 2026, an estimated $27.4K.
- Thermo Fisher Scientific made up 0.53% of NVWM LLC's portfolio in Q2 2026, its #50 holding.
- NVWM LLC first reported a position in Thermo Fisher Scientific in Q4 2017 and has held it in 35 quarters since.
- NVWM LLC's Thermo Fisher Scientific position peaked at $3.23M in Q4 2021.
- 1,244 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.
Based on NVWM LLC's 13F filing for Q2 2026, filed 29 Jul 2026.